Positive developments for AVITA in a competitive...

Positive developments for AVITA in a competitive landscape:

RenovaCare Provides Clinical and Corporate UpdateScottsdale, AZ – March 09, 2022

… the Company has suspended patient enrollment in its clinical study and plans to reduce its administrative overhead. Patients previously enrolled and treated with RenovaCare therapies and technologies will continue to receive ongoing care as per the FDA protocol. The clinical study and IDE remain open for possible resumption, and enrollment in the study may continue once the adverse impacts of the pandemic abate and capital funding becomes available…

https://www.renovacareinc.com/2022/03/renovacare_provides_clinical_and_corporate_update/